ProfileGDS5822 / ILMN_2714442
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 23% 45% 28% 58% 11% 38% 29% 15% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 113.623
GSM1276600PDAC Late Ablation Control 222.145
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.128
GSM1276603PDAC Late Ablation 228.658
GSM1276604PDAC Late Ablation 38.511
GSM1303940PDAC Late Ablation_anti-CTLA4 117.938
GSM1303941PDAC Late Ablation_anti-CTLA4 214.229
GSM1303942PDAC Late Ablation_anti-CTLA4 38.815